Consensus Cloud Solutions, Inc. ((CCSI)) has held its Q2 earnings call. Read on for the main highlights of the call.
Consensus Cloud Solutions delivered a confident, execution‑driven earnings call that highlighted steady growth, resilient profitability, and strong cash generation. Management emphasized momentum in the corporate channel, continued upmarket penetration, and early wins in healthcare and public sector, while acknowledging SoHo weakness, near‑term margin pressure, and a leveraged balance sheet as manageable trade‑offs.
Consolidated Revenue and Growth
Consensus reported Q2 2026 consolidated revenue of $91.4 million, up 4.1% year over year and 3.3% sequentially, marking the fifth straight quarter of top‑line growth. The company framed this as evidence that its transition toward larger customers and higher‑value workflows is gaining traction despite lingering headwinds in its legacy base.
Corporate Channel Milestone
The corporate segment was the growth engine, with revenue hitting a record $60.5 million, up 9.3% from a year ago and about 3% sequentially. Management highlighted this as the first time corporate revenue has surpassed the $60 million mark, underscoring the success of its strategy to move upmarket and deepen relationships with larger enterprises.
Customer Expansion and Retention
Corporate customers rose to roughly 67,000, a 9.4% increase year over year, while average revenue per account hovered around $305, up about 1%. Trailing twelve‑month net revenue retention reached 103.1%, up around 110 basis points from Q1, signaling that existing clients are steadily expanding their spend rather than churning.
Profitability and Margin Strength
Adjusted EBITDA came in at $48.3 million, a modest 0.5% increase year over year, translating to a robust 52.9% margin. That keeps Consensus squarely within its 50% to 55% target band, showing that it can fund growth investments while still maintaining one of the healthier profitability profiles among software‑like communications providers.
Free Cash Flow and Capital Returns
Free cash flow in Q2 climbed to $25.5 million, up about 25% versus last year, and management expects roughly $106 million for the full year, similar to 2025 levels. The company repurchased around $9.6 million of stock, or 300,000 shares, and its board raised the buyback authorization to $200 million, leaving approximately $118 million still available.
Product and Go‑to‑Market Progress
Consensus launched the general availability of its new eFax platform in Q2, reporting a smooth rollout and encouraging early adoption metrics. The company also said its eFax Protect product achieved record sign‑ups, and it plans mobile enhancements and migration tools in Q3 to accelerate customer onboarding and deepen usage.
Healthcare Strategy and Targeted M&A
The company formalized a Healthcare Strategy and Solutions group under industry veteran Steve Tolle to focus on clinical workflows and interoperability. It also closed a tuck‑in acquisition of doc.health, a 14‑person firm whose technology is expected to advance Consensus’s Harmony vision and expand its healthcare workflow capabilities over time.
Public Sector Traction — VA Mandate
Consensus scored a notable public sector win as the VA issued a policy mandating an ECFax solution powered by eFax, with rollout progress estimated between 65% and 80%. Management expects this relationship to contribute more than $9 million in revenue in 2026 and views its FedRAMP Class D certification as a key credential for broader government opportunities.
Balance Sheet and Liquidity
The company ended Q2 with about $99 million of cash, up $6.6 million sequentially, and reported capital expenditures of $7.8 million. Net debt‑to‑EBITDA stood at 2.45x and total debt‑to‑EBITDA at 2.97x, as management detailed a debt stack that includes 6.5% notes of $348 million, a $146 million term loan, and a $64 million revolver.
Noncash Investment Gain
Consensus recognized a $5.3 million noncash GAAP gain from revaluing an investment in a strategic AI partner following a new funding round. While this boosts reported earnings, management implicitly framed it as non‑core, with the strategic value of the partnership more important than the accounting uplift.
SoHo Revenue Decline and Volatility
SoHo revenue fell to $30.9 million, down 4.7% year over year, though that was a better result than the 9.5% drop in Q1. The company expects SoHo revenue to decline about 5% to 7% annually over the next two quarters and is prioritizing cash and margin over subscriber growth, accepting volatility in customer counts and ARPA as it harvests this segment.
Near‑Term Margin Pressure from Hiring and Audit Costs
Headcount has increased from about 520 to 550 employees this year, or roughly 32 net new hires, leading to higher compensation expenses. Management also flagged about $1.3 million in additional audit and professional fees to be expensed in Q3 and again in Q4, which will pressure margins sequentially even as underlying operations remain strong.
Debt Leverage and Interest Burden
Total debt stands around $558 million, anchored by sizeable 6.5% high‑yield notes, which keeps leverage near 3x EBITDA and embeds a meaningful interest burden. While current cash flows comfortably cover obligations, the company’s capital allocation decisions, including buybacks and M&A, must navigate this leverage profile carefully.
Conservative Guidance Despite Outperformance
Despite beating Q2 expectations, Consensus chose to reaffirm, rather than raise, its full‑year 2026 outlook, citing a conservative posture and macro uncertainty. Management did indicate it now expects full‑year revenue to land between the midpoint and high end of the range and EBITDA and EPS to come in slightly above the midpoint.
Near‑Term Dilutive Impact of doc.health Acquisition
The doc.health acquisition has been embedded into guidance with an estimated full‑year revenue contribution of around $1 million but a drag of $0.6 million on EBITDA. Management also forecast a roughly $0.02 hit to EPS, underscoring that the deal is strategically important for the roadmap but modestly dilutive in the near term.
Uncertainty and Timing in Public Sector Ramp
While bullish on long‑term public sector potential, management avoided giving detailed site or volume metrics for the VA rollout and cautioned that government sales cycles remain lengthy. They stressed that site counts do not directly translate into usage, leaving the pace of revenue build from this channel somewhat uncertain in the near term.
Guidance Share‑Count Disclosure Anomaly
The call included an apparent anomaly as Q2 non‑GAAP share count was cited at 90.2 million while full‑year guidance referenced about 19.2 million shares. Management did not address the discrepancy, which could create confusion among investors trying to reconcile EPS guidance with the reported share base.
Outlook and Forward‑Looking Guidance
Consensus reaffirmed 2026 revenue guidance of $350 million to $364 million, with a midpoint of $357 million, and expects adjusted EBITDA between $182 million and $193 million and EPS between $5.55 and $5.95. For Q3, the company guided to revenue of $89.2 million to $93.2 million, adjusted EBITDA of $45 million to $48 million, and EPS of $1.34 to $1.44, while targeting full‑year free cash flow of about $106 million and embedding SoHo declines and doc.health dilution into its outlook.
Consensus Cloud’s earnings call painted a picture of a company steadily shifting toward higher‑value corporate, healthcare, and public sector workflows while managing down its legacy SoHo base. For investors, the story is one of solid growth, strong margins, and robust cash returns, offset by leverage, near‑term cost pressure, and some guidance quirks that warrant ongoing scrutiny.
Trending Articles:
This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.